DIAGNOSIS: The benefits of finasteride for treating benign prostatic hyperplasia (BPH) are substantial. DHT is responsible for the development of BPH and the development of BPH in men with BPH. The combination of 5-alpha reductase inhibitors (5ARI) and a 5ARI is recommended to decrease the chances of developing BPH. A 5ARI is also recommended to reduce the incidence of BPH and BPH-related sexual dysfunction. Finasteride is an inhibitor of 5-alpha reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT), which in turn may cause the symptoms of BPH and other sexual dysfunction. In the United States, finasteride is only approved for use in men. DHT is also found in semen. DHT is not associated with prostate cancer. The risk of developing BPH is greater with higher doses. It is important to note that not all men with BPH, or BPH that is not treated with 5-alpha reductase inhibitors, will have a prostate biopsy to confirm the diagnosis of BPH. In addition, not all men with BPH or BPH that are treated with finasteride will develop prostate cancer. Therefore, the use of finasteride in men with BPH or BPH that are treated with 5-alpha reductase inhibitors is not recommended. For patients with moderate to severe BPH, DHT may be treated with topical finasteride applied to the prostate, or oral finasteride (5-mg daily or 5-mg daily) taken daily for 5 days. The combination of 5-alpha reductase inhibitors and a 5ARI is recommended to reduce the risk of developing BPH and the incidence of BPH.
Finasteride, a widely used medication for male pattern baldness (androgenetic alopecia), has been associated with significant hair loss, particularly in men over 40 years old. The global prevalence of men experiencing male pattern baldness (MPB) has been increasing rapidly, leading to a concern that it could have a serious impact on self-esteem and confidence in the future. In recent years, there has been an increase in interest in treating MPB with other treatments, including medications, medical devices, and lifestyle interventions [
,
].
The current study aims to evaluate the efficacy of finasteride as a treatment for MPB in a patient population using the International Index of Erectile Function (IIEF) questionnaire [
This was a retrospective study involving patients with a diagnosis of MPB who received finasteride as a treatment for MPB. The patients were randomly selected from the Department of Dermatology at a dermatology clinic in the United States. The study was approved by the Institutional Review Board of the National Institute of Health (IRB No: IHT084-16). The patients provided written informed consent before the study was conducted. The study was conducted according to the principles of the Declaration of Helsinki. The study was registered at the International Clinical Trials Registry Platform (IDCTN10124003217).
The patients who participated in this study were all female with a mean age of 39 years (SD=13.8) and diagnosed with MPB. The mean initial and follow-up periods for the patients included 3 years and 1 year, respectively.
The diagnosis of MPB was made using the IIEF questionnaire (
), which contains questions related to the domains of IIEF-EF and sexual function. The IIEF questionnaire is a well-known questionnaire used to assess the sexual function of men with MPB [
According to the ICD-10 criteria, the IIEF questionnaire consists of questions about the IIEF domain and the sexual function domain, which is a global questionnaire that measures a range of physical, emotional, and mental health [
According to the American Society of Clinical Dermists (ASD) criteria, the IIEF questionnaire is a comprehensive questionnaire that contains a comprehensive assessment of the general medical, sexual, and sexual health domains of the IIEF [
The patients' medical history, medications, and the presence of any sexual dysfunction (including sexual impotence, sexual arousal disorder, and erectile dysfunction) were evaluated. The patients were asked to complete a complete questionnaire (
), which included the IIEF questionnaire, the sexual function domain (
, and sexual interest) domain, and a validated sexual function domain (
).
The patients were also asked to complete a questionnaire on the IIEF and sexual function domains.
Of the 12 eligible patients, 8 were excluded from the study due to the incomplete and incomplete questionnaire (n=1), resulting in a total of 8 patients. A total of 5 patients had a diagnosis of MPB and had undergone a surgical procedure. After a median follow-up period of 4.9 years (range, 0.5–9.1 years), 4 patients had a diagnosis of MPB, 4 had a diagnosis of benign prostatic hyperplasia, and 2 had a diagnosis of MPB, respectively. Of the 5 patients who had received finasteride, 1 received finasteride 1 mg, and 1 received finasteride 5 mg. The median time to hair loss was 1.5 years (range, 0.5–9.1 years) for the finasteride group and 1.3 years (range, 0.5–9.1 years) for the placebo group.
In the placebo group, 5 of the 6 patients (53.2%) had a diagnosis of benign prostatic hyperplasia, and 2 of the 5 patients (42.6%) had a diagnosis of MPB. However, the patients in the finasteride group had a mean prostate volume of 31.4 L (range, 17.6 to 48.9 L) and a mean prostate specific antigen (PSA) of 79.6% (range, 47.2 to 89.0) at baseline. At 1 year, the mean prostate volume was 6.1 L (range, 3.9 to 17.6 L) in the finasteride group and 5.
Finasteride is used to treat symptoms of benign prostatic hypertrophy (BPH), such as frequent and difficult urination. Besides this, it is also used to treat male pattern hair loss.
Finasteride contains Finasteride, which works by blocking the action of male hormones that cause prostate enlargement and hair loss. Thereby, it helps treat BPH and male pattern hair loss.
In some cases, Finasteride may cause low sexual desire, impotence (erectile dysfunction), abnormal ejaculation, or trouble having an orgasm. Most of these side effects of Finasteride may not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Do not take Finasteride if you are allergic to any of its components. Finasteride is not intended for use in women and children. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.
Treatment of benign prostatic hypertrophy (BPH) and male pattern hair loss.
Finasteride belongs to a class of medicines called 5-alpha-reductase inhibitors used to treat symptoms of benign prostatic hypertrophy (BPH) in men with enlarged prostate. It also may decrease the need for prostate surgery. Additionally, it is also used to treat male pattern hair loss. Finasteride works by blocking the action of male hormones that cause the prostate to enlarge and hair loss.
• Finasteride can be taken with or without food. • It is usually taken once daily at the same time each day or as prescribed by your doctor. • Swallow Finasteride as a whole with a glass of water. • Do not crush, chew, or break it.
Store in a cool and dry place away from sunlight
Do not take Finasteride.
Women who are pregnant, might be pregnant, or might be breastfeeding should not take Finasteride.
In addition, Finasteride may cause side effects in men who are undergoing men's changes of lifestyle. Most of these side effects may not require medical attention and gradually resolve over time. If the side effects worsen, please consult a doctor.
Finasteride should not be used in women or children.
More specifically, if any side effects trouble losing an erection, such as sudden dizziness, headache, and nausea, chest pain, or sweating, low sexual desire, impotence, or abnormal ejaculation, low sexual desire, impotence, and trouble having an orgasm, or are mild,erest of the side effects may affect how well about to have an orgasm.
Women who are pregnant or might be pregnant or might be pregnant or may be breastfeeding, or might be breastfeeding should not take Finasteride. Finasteride may cause side effects in men who are undergoing men's changes of lifestyle. If the side effects may worsen, please consult a doctor.
Women who are pregnant or might be pregnant or might be pregnant or might be pregnant or breastfeeding should not take Finasteride. If the side effects may improve, please consult a doctor.
We have with us superior qualityFinpecia / Finasteride Tabletswhich are well known among our customers for their high efficiency and negligible side effects. Our offered medicines are primarily used as treatment for prostate under doctors guidance in various hospitals and clinics. We procure these medicines from trustworthy vendors, which makes them pure and precisely formulated.
Mehadia Tradelinks is the leading exporter of pharmaceutical products and medicines in India.We provide the best quality medicines and quick services for all customers around the globe with all necessary tracking information of the products.We are a specialist in Finasteride Tablets like Finast, Finpecia, Finalo and many more.
We have strong global networks in United States, Europe, United Kingdom, China, Japan, Russia, Ukraine, Dubai, Unites Arab Emirates, Thailand, Vietnam, Africa, Middle East and South East Countries.
Delivery Details :
Destination | Delivery Time |
India | 24-48 Hours |
China / Hong Kong / Singapore/ Malaysia | Within 4-5 Working Days |
Vietnam / Philipines / Indonesia | Within 6 Working Days |
Uk / Usa / Europe / South America / Uae / Canada / Australia & Rest Of The Countries | Within 7 Working Days |
* Keep to good-quality medicine and quick services for your patients.
Always consult our customer FAQwe service more than 80% of the customers worldwide. We offer superior quality medicines and fast orders. We also supply excellent quality services to your customers.
Fastest Delivery
Deliveries are delivered to your doorstep 12 - 24 hours after the medicines are prescribed and sent.
Treating hair loss is a challenge that many men face. This can be a difficult task, especially when it comes to managing hair loss, but there are treatments that can help.
The goal of treatment is to improve hair growth and prevent further hair loss. In some cases, hair loss can be caused by genetics, hormonal imbalances, or other factors. Treatment options include medications and supplements, but it’s important to be aware of these options to make informed choices.
Some treatments may not be suitable if you have hair loss concerns. Hair loss treatments can help to improve hair growth and prevent further hair loss.
Finasterideis a medication that is used to treat hair loss in men. It works by blocking the conversion of testosterone to dihydrotestosterone (DHT) in the scalp. DHT can cause hair follicles to shrink, leading to shorter and thinner hairs. Finasteride is available in tablet and liquid form and can be used alongside other treatments.
Minoxidilis a treatment that has been shown to be effective in reducing hair loss and promoting hair growth in some men. It works by increasing blood flow to the hair follicles, which can help stimulate new hair growth.
Hair transplantis another treatment that is used to treat hair loss. It works by stimulating the hair follicles, which can help restore hair growth and promote new hair growth.
Oral medicationsand supplements can also be used to treat hair loss. These medications are typically taken orally with or without food. They can help to stimulate hair growth and prevent further hair loss.
can be used to treat hair loss in men. It works by increasing blood flow to the scalp, which can improve hair growth and prevent further hair loss.
Minoxidil oral liquidIt works by stimulating hair follicles to produce new hair, which can help to promote new hair growth and prevent further hair loss.
Minoxidil topicalis a topical solution that has been shown to be effective in treating hair loss. It can be used as a hair transplant or as a treatment for hair loss.
Oral finasterideThe medication comes in tablets and is taken orally, with or without food. It is available in both oral and topical formulations.
is a procedure that involves transplanting a healthy hair into a recipient area. This can help to stimulate new hair growth and promote new hair follicles.
is a procedure that involves using a specialized laser device to stimulate hair follicles to grow new hair. It can be used in conjunction with other treatments such as hair transplants or hair regrowth in conjunction with other treatments.
is a prescription medication that is used to treat hair loss in men. It works by blocking the conversion of testosterone to dihydrotestosterone (DHT) in the scalp, which can help stimulate hair growth and prevent further hair loss. It comes as a cream and is taken orally, with or without food.
Oral finasteride topical
Minoxidil comes as a tablet and is taken orally, with or without food.
is a liquid treatment that is used to treat hair loss.
Stade de France Pharmacy